Bruce Ling, Ph.D., is a Principal Investigator at Stanford University, where they focus on translational medicine within the Department of Surgery. Previously, they served as a Senior Scientist at Stanford University from 2006 to 2010, contributing to innovative programs aimed at improving pediatric healthcare through biotechnology. They held various leadership roles in research and development at companies such as Amgen Inc., Double Twist, and Tularik Inc., from 1999 to 2005. Bruce is currently pursuing education at Stanford University, UCLA, and Fudan University.
This person is not in any teams
This person is not in any offices